Andrea De Lerma Barbaro

Author

Also Known As

A De Lerma Barbaro, A. Barbaro, A. DE LERMA BARBARO, A. De Lerma Barbaro, A. de Barbaro, ANDREA DE LERMA BARBARO, Andrea De Lerma Barbaro, Andrea De Lerma Barbaro, Andrea De Lerma Barbaro, Andrea De Lerma Barbaro

Publications

Citations

H-Index

Concepts

All Affiliations

University of Insubria University of Verona University of Genoa Ospedale Policlinico San Martino University of Pavia

About

Andrea De Lerma Barbaro is an author at University of Insubria specializing in immunology, medicine, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	203
2	Immunology	7	7	203
3	Cell Biology	6	6	161
4	Allergy	1	1	21
5	Molecular Biology	1	1	35

Andrea De Lerma Barbaro

Publications

601

Citations

H-Index

Page 1

	Year	Citations
CIITA-Induced MHC Class II Expression in Mammary Adenocarcinoma Leads to a Th1 Polarization of the Tumor Microenvironment, Tumor Rejection, and Specific Antitumor Memory Lorenzo Mortara, Patrizia Castellani, Raffaella Meazza, Clinical Cancer Research	2006	98
HLA Class II Expression in Uninducible Hepatocarcinoma Cells After Transfection of <i>AIR-1</i> Gene Product CIITA: Acquisition of Antigen Processing and Presentation Capacity Silvia Sartoris, Maria Teresa Valle, Andrea De Lerma Barbaro, The Journal of Immunology	1998	54
Therapy‐induced antitumor vaccination by targeting tumor necrosis factor‐α to tumor vessels in combination with melphalan Lorenzo Mortara, Enrica Balza, Francesca Sassi, European Journal of Immunology Tumor VesselsT-regulatory CellImmunologyImmunotherapeuticsImmunotherapy	2007	42
CIITA‐driven MHC‐II positive tumor cells: Preventive vaccines and superior generators of antitumor CD4<sup>+</sup> T lymphocytes for immunotherapy Valeria Frangione, Lorenzo Mortara, Patrizia Castellani, International Journal of Cancer ImmunologyImmunoeditingCd4 T Cell ResponsesImmunotherapeuticsImmune Cell Therapy	2010	39
Highly stable oligomerization forms of HIV-1 Tat detected by monoclonal antibodies and requirement of monomeric forms for the transactivating function on the HIV-1 LTR Giovanna Tosi, Raffaella Meazza, Andrea De Lerma Barbaro, European Journal of Immunology ImmunologyMolecular BiologyAntigen ProcessingViral Structural ProteinImmunotherapy	2000	35
The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication Roberto S. Accolla, Stefania Mazza, Andrea De Lerma Barbaro, European Journal of Immunology	2002	34
Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent anti-tumor-preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions Lorenzo Mortara, Valeria Frangione, Patrizia Castellani, International Immunology VaccinationCancer ImmunosurveillanceTumor GrowthImmunologyTumor Immunity	2009	32
Active suppression of the class II transactivator‐encoding <i>AIR‐1</i> locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells Silvia Sartoris, Giovanna Tosi, Andrea De Lerma Barbaro, European Journal of Immunology	1996	30
Surface protein components from entomopathogenic nematodes and their symbiotic bacteria: effects on immune responses of the greater wax moth, <i>Galleria mellonella</i> (Lepidoptera: Pyralidae) Maurizio Francesco Brivio, Andrea Toscano, Simone Maria De Pasquale, Pest Management Science	2018	30
The MHC class II transcriptional activator (CIITA) inhibits HTLV-2 viral replication by blocking the function of the viral transactivator Tax-2 Claudio Casoli, Andrea De Lerma Barbaro, Elisabetta Pilotti, Blood	2003	26

Page 1